Company said drug would not meet end points already..
Then why repeat it????? Getting excited about biomarkers...Folly...It failed
You have to question why they do this unless they want their buddies to short it. It's a joke
Yep - incredible what lemmings people are. If you're selling this, put your money into something you understand, like a sack under your bed, or maybe a CD.
Exactly, and with 35% of trial enrollees showing an effect the game is far from over. Remember that Herceptin would have failed a similar trial in Breast Cancer, and it didn't do so badly afterwards.